Zoetis to acquire Neogen animal genomics business for $160M
The Parsippany company has agreed to acquire Neogen’s animal genomics business for $160M, strengthening its Precision Animal Health portfolio and livestock innovation strategy.
Phibro Animal Health to acquire Zoetis portfolio for $350M
The deal between the New Jersey-based companies for medicated feed additive products also includes six manufacturing sites.
Former Bristol Myers-Squibb exec to lead Zoetis’ US operations
Ester Banque brings 30 years of industry experience to the Parsippany-based animal health company.
Four NJ companies named among World’s Most Ethical
Phoenix-based research company Ethisphere judged the publicly traded businesses across 200 data points on culture, environmental and social practices, ethics and compliance activities and more.
Gates Foundation awards Zoetis $15.3M for livestock-health initiative
The funding will support the Parsippany-based company's initiative to improve animal health and productivity in Sub-Saharan Africa.
NJ companies make Fortune’s ‘Change the World’ list (updated)
Four dozen firms worldwide were recognized for enacting business strategies that have had a positive impact in the world to address social or environmental issues through profit-making operations. See which Garden State organizations made the cut.
Zoetis completes Basepaws acquisition
The deal gives the Parsippany-based animal health company access to the target's extensive feline genomic and oral microbiome databases, which not only help detect traits and health conditions but are invaluable for future research and development projects.











